Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results – medRxiv   Commentaries on Twitter Results of the @WHO SOLIDARITY trial: 4 drugs tested in 11,266 patients with COVID in 405 hospitals in 30 countries:– hydroxychloroquine – lopinavir– remdesevir – interferon No clear benefit of any of them on survival. https://t.co/ohtTAFaSnc pic.twitter.com/2fO9E8zs8h — Martin […]

The post [Preprint] WHO SOLIDARITY trial results published; Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon do not improve outcomes in Covid-19 appeared first on Links Medicus.